IL138292A - Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor - Google Patents
Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitorInfo
- Publication number
- IL138292A IL138292A IL13829299A IL13829299A IL138292A IL 138292 A IL138292 A IL 138292A IL 13829299 A IL13829299 A IL 13829299A IL 13829299 A IL13829299 A IL 13829299A IL 138292 A IL138292 A IL 138292A
- Authority
- IL
- Israel
- Prior art keywords
- medicament
- treating
- preventing
- aromatase inhibitor
- mammary carcinoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
The use of estrogen formation inhibitor(s) (I) is claimed for the preparation of a topical medicament for the prophylaxis and/or treatment of breast cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98104949A EP0943333A1 (en) | 1998-03-18 | 1998-03-18 | Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis |
PCT/EP1999/001374 WO1999047143A1 (en) | 1998-03-18 | 1999-03-03 | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
IL138292A0 IL138292A0 (en) | 2001-10-31 |
IL138292A true IL138292A (en) | 2005-08-31 |
Family
ID=8231611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13829299A IL138292A (en) | 1998-03-18 | 1999-03-03 | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0943333A1 (en) |
JP (1) | JP4920822B2 (en) |
KR (1) | KR100778803B1 (en) |
CN (1) | CN1168448C (en) |
AT (1) | ATE230995T1 (en) |
AU (1) | AU751040B2 (en) |
BR (1) | BR9908885A (en) |
CA (1) | CA2324077C (en) |
CZ (1) | CZ292643B6 (en) |
DE (1) | DE59904042D1 (en) |
DK (1) | DK1063998T3 (en) |
ES (1) | ES2190201T3 (en) |
HU (1) | HU226105B1 (en) |
ID (1) | ID26965A (en) |
IL (1) | IL138292A (en) |
PL (1) | PL343100A1 (en) |
RU (1) | RU2225206C2 (en) |
SK (1) | SK285349B6 (en) |
WO (1) | WO1999047143A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042411A1 (en) * | 2000-08-30 | 2002-03-28 | Lohmann Therapie Syst Lts | Transdermal therapeutic system for the delivery of exemestane |
DE10054294A1 (en) * | 2000-11-02 | 2002-05-16 | Heinrich Wieland | Topical treatment for mastalgia |
JP4524296B2 (en) * | 2007-03-30 | 2010-08-11 | 生化学工業株式会社 | Hair growth promoter |
DE102007032468A1 (en) | 2007-07-10 | 2009-01-15 | Brätter, Christian, Dr. | Transdermal therapeutic systems containing the active substance anastrozole |
RS57635B1 (en) * | 2011-01-31 | 2018-11-30 | Lucolas M D Ltd | Cosmetic use |
US11850451B2 (en) | 2011-01-31 | 2023-12-26 | Lucolas-M.D. Ltd. | Cosmetic compositions and methods for improving skin conditions |
ES2694582T3 (en) | 2011-01-31 | 2018-12-21 | Lucolas-M.D. Ltd. | Combinations of aromatase inhibitors and antioxidants |
EP3666276A1 (en) * | 2018-12-14 | 2020-06-17 | dcic Biopharmaceutical Limited | Medication against estrogen-receptor beta (erbeta) positive breast tumor |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235893A (en) * | 1978-05-08 | 1980-11-25 | Brodie Angela M | Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis |
DE3322285A1 (en) * | 1983-06-18 | 1984-12-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | 1-ALKYL-ANDROSTA-1,4-DIEN-3,17-DIONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
FR2558373B1 (en) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | ANTI-ESTROGEN MEDICINAL PRODUCT BASED ON 4-HYDROXYTAMOXIFENE FOR PERCUTANEOUS ADMINISTRATION |
JPS6345294A (en) * | 1986-04-07 | 1988-02-26 | Shionogi & Co Ltd | Aromatase-inhibiting steroid derivative |
EP0310542B1 (en) * | 1987-10-01 | 1994-06-08 | Schering Aktiengesellschaft | Antigestagenic and antioestrogenic compounds for the treatment of hormone-dependent tumours |
FR2656310B1 (en) * | 1989-12-22 | 1992-05-07 | Roussel Uclaf | NEW STEROUID PRODUCTS COMPRISING IN POSITION 10, A SUBSTITUTED THIOETHYL RADICAL, THEIR PREPARATION METHOD AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
DE4039559A1 (en) * | 1990-12-07 | 1992-06-11 | Schering Ag | FUNCTIONALIZED VINYLAZOLES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THIS VINYLAZOLES AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS |
GB9212833D0 (en) * | 1992-06-17 | 1992-07-29 | Glaxo Group Ltd | Chemical compounds |
DE69427289T2 (en) * | 1993-03-16 | 2001-09-06 | Pfizer Inc., New York | NAPHTAL DERIVATIVES |
JPH07215992A (en) * | 1993-12-07 | 1995-08-15 | Teikoku Hormone Mfg Co Ltd | 6-or 7-substituted androsra-1,4-diene derivative |
JPH10508828A (en) * | 1994-09-14 | 1998-09-02 | セントラル シェフィールド ユニバーシティ ホスピタルズ エヌエイチエス トラスト | Controlling hair growth |
US5780050A (en) * | 1995-07-20 | 1998-07-14 | Theratech, Inc. | Drug delivery compositions for improved stability of steroids |
ATE200978T1 (en) * | 1996-03-29 | 2001-05-15 | S W Patentverwertungs Ges M B | COSMETICS OR COSMETIC COMPOSITION FOR SMOOTHING AND TIGHTENING THE SKIN IN DISTURBED SUBKINUM CONNECTIVE FAT TISSUE, PARTICULARLY IN CASE OF CELLULITE |
EP1806131A3 (en) * | 1996-07-22 | 2007-08-01 | Renovo Limited | Use of sex steroid function modulators to treat wounds and fibrotic disorders |
-
1998
- 1998-03-18 EP EP98104949A patent/EP0943333A1/en not_active Withdrawn
-
1999
- 1999-03-03 AU AU31434/99A patent/AU751040B2/en not_active Expired
- 1999-03-03 ID IDW20002095A patent/ID26965A/en unknown
- 1999-03-03 KR KR1020007010177A patent/KR100778803B1/en not_active IP Right Cessation
- 1999-03-03 ES ES99913218T patent/ES2190201T3/en not_active Expired - Lifetime
- 1999-03-03 DE DE59904042T patent/DE59904042D1/en not_active Expired - Lifetime
- 1999-03-03 CN CNB998064009A patent/CN1168448C/en not_active Expired - Lifetime
- 1999-03-03 BR BR9908885-1A patent/BR9908885A/en not_active Application Discontinuation
- 1999-03-03 AT AT99913218T patent/ATE230995T1/en active
- 1999-03-03 JP JP2000536383A patent/JP4920822B2/en not_active Expired - Lifetime
- 1999-03-03 CA CA002324077A patent/CA2324077C/en not_active Expired - Fee Related
- 1999-03-03 PL PL99343100A patent/PL343100A1/en unknown
- 1999-03-03 IL IL13829299A patent/IL138292A/en not_active IP Right Cessation
- 1999-03-03 HU HU0101005A patent/HU226105B1/en not_active IP Right Cessation
- 1999-03-03 CZ CZ20003256A patent/CZ292643B6/en not_active IP Right Cessation
- 1999-03-03 EP EP99913218A patent/EP1063998B1/en not_active Expired - Lifetime
- 1999-03-03 SK SK1342-2000A patent/SK285349B6/en unknown
- 1999-03-03 RU RU2000126276/15A patent/RU2225206C2/en active IP Right Revival
- 1999-03-03 DK DK99913218T patent/DK1063998T3/en active
- 1999-03-03 WO PCT/EP1999/001374 patent/WO1999047143A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
HU226105B1 (en) | 2008-04-28 |
EP1063998B1 (en) | 2003-01-15 |
DE59904042D1 (en) | 2003-02-20 |
JP2002506823A (en) | 2002-03-05 |
AU3143499A (en) | 1999-10-11 |
IL138292A0 (en) | 2001-10-31 |
ATE230995T1 (en) | 2003-02-15 |
PL343100A1 (en) | 2001-07-30 |
EP1063998A1 (en) | 2001-01-03 |
ES2190201T3 (en) | 2003-07-16 |
KR20010034603A (en) | 2001-04-25 |
CA2324077C (en) | 2008-07-29 |
ID26965A (en) | 2001-02-22 |
SK13422000A3 (en) | 2001-05-10 |
RU2225206C2 (en) | 2004-03-10 |
DK1063998T3 (en) | 2003-05-12 |
CN1301165A (en) | 2001-06-27 |
KR100778803B1 (en) | 2007-11-27 |
CA2324077A1 (en) | 1999-09-23 |
BR9908885A (en) | 2000-11-21 |
CN1168448C (en) | 2004-09-29 |
WO1999047143A1 (en) | 1999-09-23 |
JP4920822B2 (en) | 2012-04-18 |
AU751040B2 (en) | 2002-08-08 |
CZ20003256A3 (en) | 2001-04-11 |
HUP0101005A2 (en) | 2001-08-28 |
EP0943333A1 (en) | 1999-09-22 |
CZ292643B6 (en) | 2003-11-12 |
SK285349B6 (en) | 2006-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ285159A (en) | Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene | |
SI1556058T1 (en) | Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy | |
IL150767A (en) | Benzopyran-containing compounds and their use in manufacture of medicaments for treatment of estrogen sensitive diseases such as endometrial cancer | |
FR2791573B1 (en) | USE OF A SERENOA REPENS EXTRACT FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PROSTATE CANCER | |
CA2301032A1 (en) | A method of preventing or treating estrogen-dependent diseases and disorders | |
MXPA03005742A (en) | Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy. | |
MY164077A (en) | Compositions and uses of et743 for treating cancer | |
PL343100A1 (en) | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor | |
NZ504928A (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
HUP9901633A3 (en) | Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer | |
GB0008172D0 (en) | Therapy | |
PL357179A1 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
BR0111740A (en) | Tumor combination therapy comprising substituted acrylamoyl distamycin derivatives and alkylating agents | |
SI1140147T1 (en) | hCG THERAPY FOR THE TREATMENT OF METASTATIC BREAST CANCER | |
NZ337048A (en) | Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer | |
ZA200209835B (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites. | |
WO2001036048A8 (en) | Phorboxazole derivatives for treating cancer | |
CY1109852T1 (en) | CALCIUM SUPPLEMENT FOR LIMITATION OF PROTECTOR CANCER RISK | |
AU6739690A (en) | Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans | |
IT1314187B1 (en) | Combination of different pharmaceutical compositions, useful for treating mammary carcinoma | |
EP1385497A4 (en) | Method of preventing or treating breast, prostate and/or cervical cancer with n,n-dimethylglycine | |
AU3145400A (en) | Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin | |
NZ516564A (en) | Cancer therapy | |
MX9709683A (en) | Use of vitamin d4 derivatives for treating cancer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees | ||
NE | Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967) | ||
KB | Patent renewed | ||
EXP | Patent expired |